WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (C-Term) Peptide

Details for Product No. ABIN1383472, Supplier: Log in to see
Protein Name
  • zgc:64205
  • WIPI1
  • atg18
  • wipi49
  • MGC145296
  • ATG18
  • ATG18A
  • WIPI49
  • 4930533H01Rik
  • AW411817
  • D11Ertd498e
  • RGD1307754
  • WD repeat domain, phosphoinositide interacting 1
  • WD repeat domain, phosphoinositide interacting 2
  • wipi1
  • WIPI1
  • WIPI2
  • Wipi1
Protein Region
C-Term
Origin
Human
6
2
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (C-Term) antibody (ABIN1077376)
Characteristics 17 amino acids near the carboxy terminus of human WIPI1.
Human
Research Area Cancer, Apoptosis/Necrosis, Autophagy
Application Notes WIPI1 peptide is used for blocking the activity of WIPI1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Jeffries, Dove, Michell, Parker: "PtdIns-specific MPR pathway association of a novel WD40 repeat protein, WIPI49." in: Molecular biology of the cell, Vol. 15, Issue 6, pp. 2652-63, 2004 (PubMed).